References
- Connolly R, Stearns V (2012). Epigenetics as a therapeutic target in breast cancer. J Mammary Gland Biol Neoplasia, 17, 191-204. https://doi.org/10.1007/s10911-012-9263-3
- Haghighat S, Akbari M, Ghaffari S (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. https://doi.org/10.7314/APJCP.2012.13.11.5525
- Harquail J, Benzina S, Robichaud GA (2012). MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark, 11, 269-80.
- Huang Y, Nayak S, Jankowitz R, et al (2011). Epigenetics in breast cancer: what's new? Breast Cancer Res, 13, 225-35. https://doi.org/10.1186/bcr2925
- Kala R, Peek GW, Hardy TM, et al (2013). MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinforma, 16, 6-13.
- Kim TH, Kim YK, Kwon Y, et al (2010). Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology, 57, 734-43. https://doi.org/10.1111/j.1365-2559.2010.03686.x
- Lages E, Ipas H, Guttin A, et al (2012). MicroRNAs: molecular features and role in cancer. Front Biosci, 17, 2508-40. https://doi.org/10.2741/4068
- Lee S, Vasudevan S (2013). Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol, 768, 97-126. https://doi.org/10.1007/978-1-4614-5107-5_7
- Li S, Meng H, Zhou F, et al (2013). MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract, 209, 179-83. https://doi.org/10.1016/j.prp.2012.12.002
- Lindstrom LS, Karlsson E, Wilking UM, et al (2012). Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol, 30, 2601-8. https://doi.org/10.1200/JCO.2011.37.2482
- Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, et al (2013). Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac J Clin Oncol, 9, 53-9. https://doi.org/10.1111/j.1743-7563.2012.01548.x
- Ozgun A, Karagoz B, Bilgi O, et al (2013). MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer. Onkologie, 36, 115-8. https://doi.org/10.1159/000348678
- Parpart S, Wang XW (2013). microRNA Regulation and Its Consequences in Cancer. Curr Pathobiol Rep, 1, 71-9. https://doi.org/10.1007/s40139-012-0002-7
- Siegel R, Naishadham D, and Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Singh R, Mo YY (2013). Role of microRNAs in breast cancer. Cancer Biol Ther, 14, 201-12. https://doi.org/10.4161/cbt.23296
- Tang J, Ahmad A, Sarkar FH (2012). The Role of MicroRNAs in Breast Cancer Migration. In J Mol Sci, 13, 13414-37. https://doi.org/10.3390/ijms131013414
- Wu Z, He B, He J, et al (2013). Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate, 73, 596-604. https://doi.org/10.1002/pros.22600
- Xu J, Liao X, Wong C (2010). Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int J Cancer, 126, 1029-35.
- Xu J, Liao X, Lu N, et al (2011). Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines. Int J Cancer, 129, 2527-31. https://doi.org/10.1002/ijc.25917
- Xu Q, Sun Q, Zhang J, et al (2013). Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis, 34, 539-49. https://doi.org/10.1093/carcin/bgs374
- Yang L, Sun TT, Wang N (2012). The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008. Zhonghua Yu Fang Yi Xue Za Zhi, 46, 1009-14.
- Zhao S, Deng Y, Liu Y, et al (2013). MicroRNA-153 is tumor suppressive in glioblastoma stem cells. Mol Biol Rep, 40, 2789-98. https://doi.org/10.1007/s11033-012-2278-4
Cited by
- Down-regulation of miRNA-452 is Associated with Adriamycin-resistance in Breast Cancer Cells vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5137
- Role of MicroRNAs in the Warburg Effect and Mitochondrial Metabolism in Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7015
- Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs vol.31, pp.6, 2014, https://doi.org/10.1007/s10585-014-9664-3
- The role of microRNAs in human breast cancer progression vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-2202-8
- MicroRNA-153 Inhibits Osteosarcoma Cells Proliferation and Invasion by Targeting TGF-β2 vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0119225
- MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma vol.34, pp.2, 2015, https://doi.org/10.3892/or.2015.4051
- The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice vol.58, pp.10, 2015, https://doi.org/10.1007/s00125-015-3683-8
- miRNAs and their role in the correlation between schizophrenia and cancer vol.14, pp.6, 2016, https://doi.org/10.3892/mmr.2016.5853
- Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers vol.38, pp.6, 2015, https://doi.org/10.1007/s13402-015-0239-3
- In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer vol.19, pp.3, 2018, https://doi.org/10.3390/ijms19030910